Aytu BioPharma (AYTU) Insider Trading & Ownership → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free AYTU Stock Alerts $2.94 -0.02 (-0.68%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Aytu BioPharma (NASDAQ:AYTU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.34%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$48,480.00Number OfInsiders Selling(Last 12 Months)0 Get AYTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Aytu BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AYTU Insider Buying and Selling by Quarter Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Aytu BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2023Greg PyszczymukaInsiderBuy12,000$1.87$22,440.00 6/14/2023Joshua R DisbrowCEOBuy14,000$1.86$26,040.00 (Data available from 1/1/2013 forward) AYTU Insider Trading Activity - Frequently Asked Questions Who is on Aytu BioPharma's Insider Roster? The list of insiders at Aytu BioPharma includes Greg Pyszczymuka, and Joshua R Disbrow. Learn more on insiders at AYTU. What percentage of Aytu BioPharma stock is owned by insiders? 4.34% of Aytu BioPharma stock is owned by insiders. Learn more on AYTU's insider holdings. Which Aytu BioPharma insiders have been buying company stock? The following insiders have purchased AYTU shares in the last 24 months: Greg Pyszczymuka ($46,440.00), and Joshua R Disbrow ($50,761.62). How much insider buying is happening at Aytu BioPharma? Insiders have purchased a total of 238,371 AYTU shares in the last 24 months for a total of $97,201.62 bought. More Insider Trading Tools from MarketBeat Related Companies: GLTO Insider Transactions INDP Insider Transactions VBIV Insider Transactions COCP Insider Transactions GLYC Insider Transactions NERV Insider Transactions KALA Insider Transactions BIVI Insider Transactions SYBX Insider Transactions TCRT Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:AYTU) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
